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RMotion Versus Flow
as a Possible Nibus
for Atrial Fibrillation
I read with interest the editorial comment by Asirvatham and Gard
(1). The authors note that atrial fibrillation is more common in
athletes and long distance runners. They then posit a complex
theory (fulcrum for cardiac translatory movement) to explain the
tissue damage that occurs at the level of the inferior pulmonary
veins, as evidenced by the findings of fibrosis and fibrofatty
changes reported by Platonov et al. (2). I suggest a less complex
alternative hypothesis. Recalling the zones of West (3), perhaps
tissue damage occurs at the level of the inferior pulmonary veins,
particularly in long distance runners, because of the increased flow
that these vessels support relative to their superior counterparts.
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Reply
We thank Dr. Nessel for his comment regarding our observations (1).
e were unaware of this interesting paper describing the distribution
f blood flow in the isolated lung (2). This is certainly an intriguing
ossible explanation as to why different degrees of fibrosis may occur
round specific pulmonary veins. We should emphasize that the
easons for conduction delay at the pulmonary vein ostia and for
patial specificity for fibrotic changes are unknown at the present time.
n an interventional electrophysiology practice, the left inferior pul-
onary vein (3,4) typically shows more significant delay between the
eft atrial signal and the pulmonary vein potential than the right
nferior pulmonary vein. Further, of the pulmonary veins, the right
nferior vein may be the least likely to serve as a trigger for atrial
brillation and have qualitatively different pulmonary vein electro-
rams. The right inferior vein is also the most posterior of the
ulmonary veins because of the anterior crossing and course of the
ight lower pulmonary artery. The correlations, if any, among venousow dynamics, local fibrosis, and arrhythmogenicity of a given
ulmonary vein require exploration, and we thank Dr. Nessel for
ringing this observation to our attention.
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Coronary Atherosclerosis and
Quantitative Myocardial
Perfusion: A Relationship
Beyond Stenosis
We read with great interest the study by Naya et al. (1) on the
relationship between coronary atherosclerosis, detected by computed
tomography angiography (CTA), andmyocardial blood flow and flow
reserve (MFR), measured by positron emission tomography (PET).
Naya et al. (1) studied the association between plaque morphol-
ogy, composition, and severity, on the one hand, and myocardial
perfusion, on the other, in a population with known or suspected
coronary artery disease (CAD). They observed that the “summed
stenosis score,” an indicator of vessel atherosclerotic burden, was a
better predictor of depressed regional MFR than stenosis severity.
Moreover, the modified Duke CAD index, an indicator of the
presence and extent of significant coronary lesions, was the major
determinant of global MFR. The authors concluded that MFR is
influenced especially by the presence and severity of coronary
luminal narrowings, underplaying the influence of CTA descrip-
tors of coronary atherosclerotic burden.
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April 10, 2012:1407–11Coincidentally, we recently reported a study that analyzed the
relationships between coronary stenoses and vessel structure as-
sessed by CTA, PET-derived MFR, and cardiovascular risk factors
(2). We showed that abnormal wall structure affects regional MFR
beyond the presence and severity of coronary stenoses. Specifically,
coronary calcium content was the main determinant of regional
MFR and a significant predictor of depressed global MFR.
Interestingly, when the Framingham risk score, an indicator of
overall cardiovascular risk, was considered; it remained the only
significant determinant of global MFR, beyond CTA variables.
Although the 2 investigations are similar with regard to baseline
characteristics of patients and differ only slightly in their method-
ology, they come to apparently different conclusions. In our view,
however, both studies point to the effects of diffuse coronary
atherosclerosis, in addition to those of focal significant stenoses, on
myocardial perfusion.
Accordingly, depressed regional MFR is closely linked to the
coronary atherosclerotic burden in the related vessel, described by
the “summed stenosis score” in the study by Naya et al. (1) and by
the coronary calcium content in ours (2). Moreover, global MFR
is consistently related to different indicators of cardiovascular risk,
the Duke CAD index in the study by Naya et al. (1), and the
Framingham risk score in ours (2).
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Reply
We appreciate the commentary by Drs. Liga and Neglia regarding
the relationship between coronary anatomic features and quan-
titative myocardial flow reserve (MFR) as assessed by cardiac
hybrid positron emission tomography/computed tomography.
We agree that both studies consistently demonstrate that the
total burden of atherosclerosis, quantified with coronary cal-
cium score (1) or by the total stenosis score, which integrates
the effects of serial plaques (2), contributes to downstream
MFR more than stenosis severity alone. However, we would not
characterize MFR as being “closely linked to atherosclerotic
burden.” Rather, both studies as well as other studies using
invasive angiography (3) have demonstrated that the correlation
etween epicardial stenosis severity and quantitative measures
f perfusion, although significant, is only modest in magnitude.
his is likely due to the fact that anatomic descriptors ofepicardial stenosis cannot capture the effects of diffuse athero-
sclerosis on vasodilator function of either the epicardial coro-
nary arteries or the microvasculature. Nonetheless, we believe
that both studies add valuable insights to the literature regard-
ing the determinants and role of MFR, which will have
increasing clinical application given its powerful prognostic
significance (4).
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Limitations of Noninvasive
Measurement of Fractional Flow
Reserve From Coronary
Computed Tomography
Angiography
We read with interest the paper by Koo et al. (1) regarding the
diagnostic accuracy of noninvasive measurement of fractional flow
reserve (FFR) from coronary computed tomography angiography
data (FFRCT). We do recognize the potential clinical and eco-
nomic relevance of the validation of a diagnostic tool able to
noninvasively determine the presence of ischemia-inducing coro-
nary lesions because it would dramatically reduce the number of
diagnostic angiograms and guide subsequent coronary revascular-
ization. However, we have some concerns regarding the interpre-
tation of the results of the study.
First, the major potential drawback of FFRCT relates to the fact
that FFR is calculated during “simulated” and not “real” hyper-
emia. To this end, the authors assume that “microcirculation reacts
predictably to maximal hyperemic conditions in patients with
normal coronary flow.” This sentence is substantiated by a bibli-
ographic reference that demonstrates the reproducibility of the
